Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Services (HCSG) Accumulated Expenses (2016 - 2025)

Healthcare Services (HCSG) has disclosed Accumulated Expenses for 17 consecutive years, with $24.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Accumulated Expenses fell 3.09% to $24.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $24.4 million, a 3.09% decrease, with the full-year FY2025 number at $24.4 million, down 3.09% from a year prior.
  • Accumulated Expenses was $24.4 million for Q4 2025 at Healthcare Services, down from $50.4 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $68.7 million in Q4 2021 to a low of $1.2 million in Q3 2022.
  • A 5-year average of $32.4 million and a median of $25.2 million in 2023 define the central range for Accumulated Expenses.
  • Peak YoY movement for Accumulated Expenses: tumbled 96.78% in 2023, then surged 2936.0% in 2025.
  • Healthcare Services' Accumulated Expenses stood at $68.7 million in 2021, then tumbled by 66.26% to $23.2 million in 2022, then surged by 142.35% to $56.1 million in 2023, then plummeted by 55.21% to $25.1 million in 2024, then fell by 3.09% to $24.4 million in 2025.
  • Per Business Quant, the three most recent readings for HCSG's Accumulated Expenses are $24.4 million (Q4 2025), $50.4 million (Q3 2025), and $66.2 million (Q2 2025).